EBioMedicine

The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.

Publisher
Elsevier
Website
http://www.ebiomedicine.com/

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

COVID-19 vaccine candidate shows promise in first peer-reviewed research

University of Pittsburgh School of Medicine scientists today announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized ...

Oncology & Cancer

Radio-wave therapy proves effective against liver cancer cells

A new targeted therapy using non-thermal radio waves has been shown to block the growth of liver cancer cells anywhere in the body without damaging healthy cells, according to a study conducted by scientists at Wake Forest ...

Medical research

Researchers discover how to slow aging

Previous research published earlier this year in Nature Medicine involving University of Minnesota Medical School faculty Paul D. Robbins and Laura J. Niedernhofer and Mayo Clinic investigators James L. Kirkland and Tamara ...

page 1 from 17